🇺🇸 ABA, open-label (OL) in United States

FDA authorised ABA, open-label (OL) on 23 December 2005

Marketing authorisation

FDA — authorised 23 December 2005

  • Application: BLA125118
  • Marketing authorisation holder: BRISTOL MYERS SQUIBB
  • Local brand name: ORENCIA
  • Indication: INJECTABLE — IV (INFUSION)
  • Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is ABA, open-label (OL) approved in United States?

Yes. FDA authorised it on 23 December 2005.

Who is the marketing authorisation holder for ABA, open-label (OL) in United States?

BRISTOL MYERS SQUIBB holds the US marketing authorisation.